Loading...
XJPX6960
Market cap1.25bUSD
Jan 15, Last price  
6,780.00JPY
1D
0.15%
1Q
-9.60%
Jan 2017
110.23%
Name

Fukuda Denshi Co Ltd

Chart & Performance

D1W1MN
XJPX:6960 chart
P/E
10.46
P/S
1.39
EPS
648.43
Div Yield, %
2.81%
Shrs. gr., 5y
-0.27%
Rev. gr., 5y
1.58%
Revenues
140.32b
+4.21%
74,659,000,00086,613,000,00088,270,000,00088,568,000,00089,551,000,00088,147,000,00090,169,000,00092,524,000,00096,239,000,000107,574,000,000108,269,000,000117,222,000,000121,747,000,000128,883,000,000129,775,000,000133,393,000,000146,756,000,000132,098,000,000134,648,000,000140,323,000,000
Net income
18.69b
+8.19%
4,075,000,000605,000,0003,353,000,0003,174,000,0003,770,000,0003,498,000,0004,111,000,0005,266,000,0006,462,000,0007,559,000,0007,119,000,0007,368,000,0008,776,000,0009,320,000,0009,577,000,0009,609,000,00014,716,000,00016,216,000,00017,278,000,00018,693,000,000
CFO
23.91b
+3.36%
6,869,000,0006,462,000,0008,298,000,0005,855,000,00014,663,000,00012,195,000,00013,760,000,0008,513,000,00012,199,000,00011,122,000,00012,851,000,00011,758,000,00015,693,000,00017,852,000,00013,979,000,00020,233,000,00021,743,000,00023,111,000,00023,137,000,00023,914,000,000
Dividend
Mar 28, 20250 JPY/sh
Earnings
Jan 29, 2025

Profile

Fukuda Denshi Co., Ltd. engages in manufacture and sale of medical instruments in Japan and internationally. It offers resting electrocardiograph products; data management software; stress test products; and patient monitoring systems, including central and bedside monitors, transmitters, and central viewer workstations; and vascular screening systems. The company was founded in 1939 and is based in Tokyo, Japan.
URL
https://www.fukuda.co.jp/
IPO date
Jun 01, 1982
Employees
3,382
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑032015‑03
Income
Revenues
140,323,000
4.21%
134,648,000
1.93%
132,098,000
-9.99%
Cost of revenue
72,332,000
68,029,000
67,966,000
Unusual Expense (Income)
NOPBT
67,991,000
66,619,000
64,132,000
NOPBT Margin
48.45%
49.48%
48.55%
Operating Taxes
8,293,000
7,923,000
7,508,000
Tax Rate
12.20%
11.89%
11.71%
NOPAT
59,698,000
58,696,000
56,624,000
Net income
18,693,000
8.19%
17,278,000
6.55%
16,216,000
10.19%
Dividends
(5,492,000)
(5,253,000)
(4,564,000)
Dividend yield
2.64%
4.07%
3.86%
Proceeds from repurchase of equity
(11,248,000)
9,000
17,000
BB yield
5.40%
-0.01%
-0.01%
Debt
Debt current
2,037,000
2,054,000
2,017,000
Long-term debt
3,235,000
3,552,000
3,877,000
Deferred revenue
(1,008,000)
(766,000)
Other long-term liabilities
4,152,000
4,737,000
5,005,000
Net debt
(87,022,000)
(88,542,000)
(81,592,000)
Cash flow
Cash from operating activities
23,914,000
23,137,000
23,111,000
CAPEX
(13,464,000)
(12,539,000)
(14,358,000)
Cash from investing activities
(14,779,000)
(14,210,000)
(10,789,000)
Cash from financing activities
(17,066,000)
(5,551,000)
(4,832,000)
FCF
47,372,000
52,705,000
49,277,000
Balance
Cash
60,222,000
68,466,000
64,554,000
Long term investments
32,072,000
25,682,000
22,932,000
Excess cash
85,277,850
87,415,600
80,881,100
Stockholders' equity
178,765,000
161,558,000
148,377,000
Invested Capital
91,392,150
78,935,400
73,584,900
ROIC
70.10%
76.97%
80.73%
ROCE
38.48%
39.81%
41.31%
EV
Common stock shares outstanding
30,032
30,247
30,242
Price
6,930.00
62.49%
4,265.00
9.22%
3,905.00
-7.13%
Market cap
208,120,443
61.33%
129,003,455
9.24%
118,095,010
-7.12%
EV
121,098,443
40,461,455
36,503,010
EBITDA
77,716,000
75,987,000
73,148,000
EV/EBITDA
1.56
0.53
0.50
Interest
34,000
37,000
37,000
Interest/NOPBT
0.05%
0.06%
0.06%